Journal article
Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation
Abstract
AIMS: Beyond 1 year after percutaneous coronary intervention (PCI), guidelines recommend anticoagulant monotherapy in patients with atrial fibrillation (AF) rather than dual therapy with an anticoagulant and an antiplatelet drug. The risks and benefits of this strategy, however, remain uncertain. We examined hospitalization for bleeding and ischaemic risk beyond 1 year after PCI in patients with AF treated with monotherapy vs. dual therapy. …
Authors
Jensen T; Thrane PG; Olesen KKW; Würtz M; Mortensen MB; Gyldenkerne C; Thim T; Nørgaard BL; Jensen JM; Kristensen SD
Journal
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, No. 3, pp. 208–219
Publisher
Oxford University Press (OUP)
Publication Date
April 10, 2023
DOI
10.1093/ehjcvp/pvac058
ISSN
2055-6837